Literature DB >> 7616872

Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality.

S R Davis1, P McCloud, B J Strauss, H Burger.   

Abstract

To investigate the role of androgens in increasing bone density and improving low libido in postmenopausal women, we have studied the long-term effects of estradiol and testosterone implants on bone mineral density and sexuality in a prospective, 2 year, single-blind randomised trial. Thirty-four postmenopausal volunteers were randomised to treatment with either estradiol implants 50 mg alone (E) or estradiol 50 mg plus testosterone 50 mg (E&amp;T), administered 3-monthly for 2 years. Cyclical oral progestins were taken by those women with an intact uterus. Thirty-two women completed the study. BMD (DEXA) of total body, lumbar vertebrae (L1-L4) and hip area increased significantly in both treatment groups. BMD increased more rapidly in the testosterone treated group at all sites. A substantially greater increase in BMD occurred in the E&amp;T group for total body (P < 0.008), vertebral L1-L4 (P < 0.001) and trochanteric (P < 0.005) measurements. All sexual parameters (Sabbatsberg sexual self-rating scale) improved significantly in both groups. Addition of testosterone resulted in a significantly greater improvement compared to E for sexual activity (P < 0.03), satisfaction (P < 0.03), pleasure (P < 0.01), orgasm (P < 0.035) and relevancy (P < 0.05). Total cholesterol and LDL-cholesterol fell in both groups as did total body fat. Total body fat-free mass (DEXA, anthropometry, impedance) increased in the E&amp;T group only. We concluded that in postmenopausal women, treatment with combined estradiol and testosterone implants was more effective in increasing bone mineral density in the hip and lumbar spine than estradiol implants alone. Significantly greater improvement in sexuality was observed with combined therapy, verifying the therapeutic value of testosterone implants for diminished libido in postmenopausal women. The favourable estrogenic effects on lipids were preserved in women treated with T, in association with beneficial changes in body composition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616872     DOI: 10.1016/0378-5122(94)00898-h

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  45 in total

Review 1.  Another role highlighted for estrogens in the male: sexual behavior.

Authors:  E R Simpson; S R Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

Review 2.  Prevalence of and recent developments in female sexual dysfunction.

Authors:  R Shabsigh
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

3.  Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN).

Authors:  Joyce T Bromberger; Laura L Schott; Howard M Kravitz; Maryfran Sowers; Nancy E Avis; Ellen B Gold; John F Randolph; Karen A Matthews
Journal:  Arch Gen Psychiatry       Date:  2010-06

4.  Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: the cardiovascular health study.

Authors:  Chevon M Rariy; Sarah J Ratcliffe; Rachel Weinstein; Shalender Bhasin; Marc R Blackman; Jane A Cauley; John Robbins; Joseph M Zmuda; Tamara B Harris; Anne R Cappola
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

Review 5.  Pharmacological therapy for female sexual dysfunction: has progress been made?

Authors:  Susan R Davis; Esme A Nijland
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women.

Authors:  Irene Lambrinoudaki; George Christodoulakos; Leon Aravantinos; Aristidis Antoniou; Demetrios Rizos; Constantinos Chondros; Apostolos Kountouris; Grigorios Chrysofakis; George Creatsas
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

7.  Sexual function in infertile women with polycystic ovary syndrome and unexplained infertility.

Authors:  Michael P Diamond; Richard S Legro; Christos Coutifaris; Ruben Alvero; Randal D Robinson; Peter A Casson; Gregory M Christman; Hao Huang; Karl R Hansen; Valerie Baker; Rebecca Usadi; Aimee Seungdamrong; G Wright Bates; R Mitchell Rosen; William Schlaff; Daniel Haisenleder; Stephen A Krawetz; Kurt Barnhart; J C Trussell; Nanette Santoro; Esther Eisenberg; Heping Zhang
Journal:  Am J Obstet Gynecol       Date:  2017-04-26       Impact factor: 8.661

8.  Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial.

Authors:  Grace Huang; Shehzad Basaria; Thomas G Travison; Matthew H Ho; Maithili Davda; Norman A Mazer; Renee Miciek; Philip E Knapp; Anqi Zhang; Lauren Collins; Monica Ursino; Erica Appleman; Connie Dzekov; Helene Stroh; Miranda Ouellette; Tyler Rundell; Merilyn Baby; Narender N Bhatia; Omid Khorram; Theodore Friedman; Thomas W Storer; Shalender Bhasin
Journal:  Menopause       Date:  2014-06       Impact factor: 2.953

9.  Vitamin D3 deficiency is associated with female sexual dysfunction in premenopausal women.

Authors:  Masum Canat; Lütfi Canat; Feyza Yener Öztürk; Hatice Eroğlu; Hasan Anıl Atalay; Yüksel Altuntaş
Journal:  Int Urol Nephrol       Date:  2016-08-13       Impact factor: 2.370

Review 10.  The many faces of testosterone.

Authors:  Jerald Bain
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.